Predict your next investment

Corporation
HEALTHCARE | Pharmaceuticals / Drugs
aceto.com

See what CB Insights has to offer

Portfolio Exits

1

Partners & Customers

1

About ACETO

ACETO (NASDAQ: ACET) is an international company engaged in the development, marketing, sale, and distribution of human health products (finished dosage form generics and nutraceuticals), pharmaceutical ingredients (pharmaceutical intermediates and active pharmaceutical ingredients), and performance chemicals (specialty chemicals and agricultural protection products).

ACETO Headquarter Location

4 Tri Harbor Court

Port Washington, New York, 11050,

United States

516-627-6000

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

ACETO Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

ACETO Rank

Latest ACETO News

Aceto's expansion roll continues with buyout of Irish biopharma manufacturer

Oct 14, 2021

by Joseph Keenan Oct 14, 2021 6:55am Aceto expansion strategy continues with the purchase of Ireland's A&C Bio Buffer, marking the company’s sixth acquisition in under a year. (Getty Images) Aceto continued its aggressive expansion plans with the acquisition of A&C Bio Buffer, marking the company’s sixth acquisition in under a year. A&C Bio, which is based in Limerick, Ireland, produces biological buffers, process solutions, cleaning solutions and chemical blends for the pharmaceutical and biopharmaceutical industries. A&C Bio used to be part of A&C Group, the global manufacturer of GMP specialty excipients and custom process solutions Aceto snapped up in April. Financial terms of the A&C Bio deal weren’t disclosed. “A&C Bio Buffer is a natural add-on to our acquisition of A&C and aligns with our commitments to the biopharmaceutical space,” Gilles Cottier, CEO of Aceto, said in a statement. “It is a nimble, highly customer-centric organization serving some of the top biopharmaceutical manufacturers in Europe.” Since late last year, Aceto has picked up Oregon-based CDMO Cascade Chemistry, New York-based distributor Finar Limited and specialty materials makers Bioreagent and IsleChem.

ACETO Portfolio Exits

1 Portfolio Exit

ACETO has 1 portfolio exit. Their latest portfolio exit was ACETO - Chemicals Business on April 16, 2019.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

4/16/2019

Divestiture

2

Date

4/16/2019

Exit

Divestiture

Companies

Valuation

Acquirer

Sources

2

ACETO Acquisitions

7 Acquisitions

ACETO acquired 7 companies. Their latest acquisition was A&C Bio Buffer on October 12, 2021.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

10/12/2021

Acquired

3

6/2/2021

Subscribe to see more

$99M

Subscribe to see more

10

5/17/2021

Subscribe to see more

$99M

Subscribe to see more

10

4/15/2021

Subscribe to see more

$99M

Subscribe to see more

10

12/21/2020

Subscribe to see more

$99M

Subscribe to see more

10

Date

10/12/2021

6/2/2021

5/17/2021

4/15/2021

12/21/2020

Investment Stage

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

Total Funding

$99M

$99M

$99M

$99M

Note

Acquired

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

3

10

10

10

10

ACETO Partners & Customers

1 Partners and customers

ACETO has 1 strategic partners and customers. ACETO recently partnered with Verdezyne on October 10, 2016.

Date

Type

Business Partner

Country

News Snippet

Sources

10/4/2016

Partner

Verdezyne

United States

Verdezyne Signs Distribution Agreement With Aceto Corporation. Exclusive Agreement with Leading Distributor of Specialty Chemicals in the U.S. to Power Regional Sales of Verdezyne’s BIOLON® DDDA.

CARLSBAD , Calif. and PORT WASHINGTON , N.Y. , Oct. 4 , 2016 / PRNewswire / -- Verdezyne Inc. , a synthetic biology company producing biobased chemicals , and Aceto Corporation , the leader in the marketing , sales and distribution of specialty chemicals in the U.S. , announced an agreement for sales and distribution of Verdezyne Inc. 's BIOLON ® DDDA .

3

Date

10/4/2016

Type

Partner

Business Partner

Verdezyne

Country

United States

News Snippet

Verdezyne Signs Distribution Agreement With Aceto Corporation. Exclusive Agreement with Leading Distributor of Specialty Chemicals in the U.S. to Power Regional Sales of Verdezyne’s BIOLON® DDDA.

CARLSBAD , Calif. and PORT WASHINGTON , N.Y. , Oct. 4 , 2016 / PRNewswire / -- Verdezyne Inc. , a synthetic biology company producing biobased chemicals , and Aceto Corporation , the leader in the marketing , sales and distribution of specialty chemicals in the U.S. , announced an agreement for sales and distribution of Verdezyne Inc. 's BIOLON ® DDDA .

Sources

3

ACETO Team

1 Team Member

ACETO has 1 team member, including former Chief Executive Officer, Chief Operating Officer, Salvatore Guccione.

Name

Work History

Title

Status

Salvatore Guccione

Chief Executive Officer, Chief Operating Officer

Former

Name

Salvatore Guccione

Work History

Title

Chief Executive Officer, Chief Operating Officer

Status

Former

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.